The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

What Happened? A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Teladoc stock has declined significantly, from a high of $14 per share in February to $7 per share. Read why I downgrade TDOC ...

The shortage, which began in December 2022 for Mounjaro and extended to Zepbound in April 2023 ... with shares of Hims & Hers Health, a company offering compounded versions of GLP-1 treatments ...

Companies like Hims & Hers and WeightWatchers have been ... approved, and studied Zepbound for patients who are being asked to pay out-of-pocket," he added. Jonsson also told Reuters that more ...

Through all the market madness of the past two years, there has been one truth universally acknowledged by the analysts who ...

Mounjaro Versus Zepbound ! What Medications Does Hims Prescribe prevent these three thieves from disturbing Yang Ziwei s peaceful life. ACV Keto Gummies: A Powerful Weight Loss Combination for Women ...